학술논문
A Nationwide Observational Study of Ponatinib in CML Patients Outside of Clinical Trials- The Israeli Experience
Document Type
Abstract
Author
Source
In Clinical Lymphoma Myeloma and Leukemia September 2016 16 Supplement 2:S64-S64
Subject
Language
ISSN
2152-2650